Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Pediatrix Medical Group Inc’s stock clocked out at $12.08, up 0.67% from its previous closing price of $12.00. In other words, the price has increased by $0.67 from its previous closing price. On the day, 0.54 million shares were traded. MD stock price reached its highest trading level at $12.25 during the session, while it also had its lowest trading level at $11.985.
Ratios:
To gain a deeper understanding of MD’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.79 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.33. For the most recent quarter (mrq), Quick Ratio is recorded 1.38 and its Current Ratio is at 1.38. In the meantime, Its Debt-to-Equity ratio is 0.99 whereas as Long-Term Debt/Eq ratio is at 0.94.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 26, 2024, Upgraded its rating to Buy and sets its target price to $14 from $8 previously.
On June 07, 2024, Deutsche Bank Upgraded its rating to Hold which previously was Sell but kept the price unchanged to $8.
On September 27, 2021, SVB Leerink started tracking the stock assigning a Mkt Perform rating and target price of $29.SVB Leerink initiated its Mkt Perform rating on September 27, 2021, with a $29 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 30 ’24 when Swift James D sold 11,100 shares for $10.79 per share. The transaction valued at 119,769 led to the insider holds 170,001 shares of the business.
Swift James D bought 11,100 shares of MD for $119,756 on Aug 30 ’24. On Aug 27 ’24, another insider, Linynsky Laura A, who serves as the Director of the company, sold 7,000 shares for $11.16 each. As a result, the insider received 78,120 and left with 30,805 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 1037258880 and an Enterprise Value of 1585978752. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 1.47. Its current Enterprise Value per Revenue stands at 0.792 whereas that against EBITDA is 8.355.
Stock Price History:
Over the past 52 weeks, MD has reached a high of $13.01, while it has fallen to a 52-week low of $6.62. The 50-Day Moving Average of the stock is 19.11%, while the 200-Day Moving Average is calculated to be 33.76%.
Shares Statistics:
It appears that MD traded 652.36K shares on average per day over the past three months and 745910 shares per day over the past ten days. A total of 85.87M shares are outstanding, with a floating share count of 84.59M. Insiders hold about 1.49% of the company’s shares, while institutions hold 102.26% stake in the company. Shares short for MD as of 1726185600 were 4792745 with a Short Ratio of 7.35, compared to 1723680000 on 5008612. Therefore, it implies a Short% of Shares Outstanding of 4792745 and a Short% of Float of 7.870000000000001.
